120
Participants
Start Date
November 24, 2017
Primary Completion Date
August 31, 2022
Study Completion Date
September 23, 2022
NT-501
"Each NT-501 implant consisted of hCNTF-secreting NTC-201-6A.02 cells encapsulated within supportive matrices and surrounded by a semipermeable polymer membrane.~The NTC-201-6A cells continuously secrete CNTF from the NT-501 implant into the vitreous cavity. Implanted by a qualified Health Care Professional."
Sham Procedure
The sham surgery involved a superficial conjunctival incision performed under local anesthetic and closure with a single suture.
Lions Eye Institute, Perth
National Institute of Health, NIH, Bethesda
Cumberland Valley Retina Consultants, Hagerstown
Southeastern Retina Associates, PC, Knoxville
Retina Associates of Cleveland, Inc., Cleveland
Associated Retinal Consultants, P.C., Royal Oak
Retina Associates of New Orleans, Metairie
Tulsa Retina Consultants, Tulsa
Lariboisiere Hospital, Paris
Texas Retina Associates, Dallas
Retina Consultants of Southern Colorado, P.C., Colorado Springs
University of Utah John A. Moran Eye Center, Salt Lake City
Sierra Eye Associates, Reno
Jules Stein Eye Institute / David Geffen School of Medicine, Los Angeles
Scripps Clinic Medical Group, La Jolla
Byers Eye Institute at Stanford University, Palo Alto
Bay Area Retina Associates, Walnut Creek
Retina Northwest, PC, Portland
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford
Moorfields Eye Hospital NHS Foundation Trust, London
Lead Sponsor
The Lowy Medical Research Institute Limited
OTHER
Neurotech Pharmaceuticals
INDUSTRY